In this article
- What each one is and how it works
- At-a-glance comparison
- What the evidence actually shows
- Side effects and safety
- Can you combine metformin and inositol?
- How to choose
- Is metformin FDA approved for PCOS, and what about inositol?
- Who prescribes metformin or guides inositol use for PCOS?
- Where do GLP-1 medications fit next to metformin and inositol?
- Frequently asked questions
- Related reading
- Frequently Asked Questions
The short answer: Metformin and inositol produce similar improvements in insulin and testosterone levels in women with PCOS, according to a meta-analysis of six randomized trials and 355 women by Facchinetti and colleagues (2019), but metformin has the stronger evidence for hirsutism and waist size while inositol causes far fewer digestive side effects. The 2023 International Evidence-based Guideline for PCOS recommends metformin for metabolic features and says inositol may be considered based on personal preference.
What this article covers
Both metformin and inositol target the insulin resistance that drives many PCOS symptoms. The practical difference is tolerability and evidence strength. Metformin has the larger evidence base and is the medication most guidelines recommend first for metabolic features, while inositol (a supplement) tends to cause far fewer digestive side effects but rests on weaker, less consistent data. Metformin is a prescription drug and needs medical supervision. Many people end up choosing based on side effects, cost, and how their clinician reads the evidence, and some use both together.
Key takeaways
- Metformin and myo-inositol showed no significant difference in fasting insulin, HOMA-IR or testosterone in a 2019 meta-analysis of six randomized trials and 355 women (Facchinetti, Gynecological Endocrinology).
- The 2023 International Evidence-based Guideline for PCOS (Teede and colleagues) says metformin should be considered over inositol for hirsutism and central adiposity.
- Myo-inositol likely causes fewer gastrointestinal side effects than metformin, according to the review by Fitz and colleagues (2024) that informed the 2023 guideline.
- Metformin is a prescription drug approved by the FDA for type 2 diabetes and used off label in PCOS; inositol is a dietary supplement that the FDA does not approve before sale.
- The 2023 guideline states that no specific inositol type, dose or ratio, including the popular 40:1 myo to D-chiro blend, can currently be recommended because quality evidence is lacking.
- Combining metformin and inositol is biologically reasonable, but small trials have not shown that the combination is clearly superior for everyone.
What each one is and how it works
Polycystic ovary syndrome (PCOS) often involves insulin resistance, meaning the body produces more insulin to keep blood sugar normal. High insulin can push the ovaries to make more testosterone, which contributes to irregular cycles, acne, and unwanted hair growth (hirsutism). Both treatments aim at this underlying insulin problem, but through different routes.
Metformin
Metformin is a prescription medication that has been used for decades in type 2 diabetes. It belongs to the biguanide class and is sold as a low-cost generic. It mainly works by reducing the amount of glucose the liver releases and by making cells more responsive to insulin.
In PCOS, lowering insulin can in turn lower androgen levels and, for some people, help restore more regular ovulation. It is taken as a tablet, usually once or twice a day, and an extended-release version (metformin ER or XR) is available. Because it is a drug, it requires a prescription and ongoing clinical oversight.
Inositol
Inositol is a sugar-like compound the body makes naturally and also gets from food such as citrus fruit, beans and whole grains. Two forms matter most in PCOS: myo-inositol (MI) and D-chiro-inositol (DCI). They act as second messengers inside cells, helping relay insulin’s signal. Myo-inositol is also involved in the FSH signaling pathway in the ovaries, which is part of why researchers connect it to ovulation and egg quality.
Most healthy tissues hold roughly a 40:1 ratio of myo to D-chiro inositol, and many supplements are formulated at that 40:1 ratio to mirror normal physiology. Inositol is sometimes still called vitamin B8, although it is not a true vitamin. It is sold over the counter as a supplement, not a regulated drug, so product quality and dosing can vary between brands.
At-a-glance comparison
The table below compares metformin and inositol on the attributes people weigh most when choosing between them for PCOS.
| Feature | Metformin | Inositol (MI or MI:DCI 40:1) |
|---|---|---|
| Type | Prescription medication | Over-the-counter supplement |
| Regulatory status | FDA approved for type 2 diabetes, off label for PCOS | Dietary supplement, not FDA approved for any condition |
| Main mechanism | Lowers liver glucose output, improves insulin sensitivity | Acts as insulin second messenger, supports FSH signaling |
| Insulin resistance | Improves (well documented) | Improves (similar in head-to-head trials) |
| Androgens (testosterone) | Tends to lower | Tends to lower |
| Hirsutism and waist size | Favored by the 2023 guideline | Weaker effect in head-to-head trials |
| Typical side effects | Nausea, diarrhea, cramping; possible B12 lowering long term | Usually mild nausea or bloating; far fewer overall |
| Evidence strength | Larger, more consistent | Limited and less consistent |
| Guideline status (2023) | Recommended for metabolic features | May be considered based on preference |
| Supervision | Requires prescriber and monitoring | Best discussed with a clinician |
What the evidence actually shows
Several randomized trials have compared the two directly. A systematic review and meta-analysis pooling six trials of 355 women with PCOS found that myo-inositol and metformin produced similar improvements in insulin and testosterone levels, according to Facchinetti and colleagues (2019). In other words, on the core metabolic and hormonal markers, the two often land in a comparable place.
The picture gets less tidy for clinical outcomes you can see and feel, like ovulation, weight, and hirsutism. Some trials report better ovulation and pregnancy rates with inositol, while the 2023 International Evidence-based Guideline for PCOS concluded that metformin appears superior for outcomes such as waist-to-hip ratio and hirsutism score. That guideline recommends metformin for metabolic features, particularly in adults with a BMI of 25 or higher, and notes that the evidence for inositol on clinical outcomes was not strong enough to make firm efficacy recommendations. It positions inositol as something that may be considered based on individual preferences, given its low risk of harm.
Which review should you trust?
Two large reviews read the same body of trials differently. Greff and colleagues (2023), pooling 26 randomized trials, concluded that inositol was non-inferior to metformin on most outcomes. Fitz and colleagues (2024), the review commissioned for the 2023 guideline, pooled 30 trials and judged the evidence for inositol limited and inconclusive, with metformin ahead on waist-to-hip ratio and hirsutism.
Part of the difference comes from how each team graded study quality and which comparisons it pooled. Many inositol trials are small, short and use different forms and doses, which lowers the certainty grade in a guideline process.
So the honest summary is this: metformin has the more robust and consistent evidence base, especially for metabolic endpoints, while inositol shows promise but rests on smaller, more variable studies. If you see a confident claim that one is clearly better across the board, treat it with caution, because the data do not support that level of certainty. For a deeper look at the insulin piece, see our guide to PCOS and insulin resistance.
Side effects and safety
Metformin
The most common issues are gastrointestinal: nausea, diarrhea, gas, and cramping. These are usually worst at the start and often ease over time, especially when the dose is increased slowly and taken with food. The extended-release form tends to be gentler on the stomach.
Over long-term use, metformin can lower vitamin B12 absorption, so periodic B12 checks are reasonable if you have symptoms like fatigue, anemia, or nerve tingling. Lactic acidosis is a rare but serious risk, and it is more likely in people with significant kidney impairment, heavy alcohol use, or acute illness. Metformin is generally avoided when kidney function (eGFR) is below 30, as the MedlinePlus metformin drug information page from the National Library of Medicine explains. Because of all this, dosing and monitoring should be handled by a prescriber.
Inositol
Inositol is well tolerated for most people. Side effects, when they occur, are usually mild and limited to nausea or bloating at higher doses. The 2023 guideline review by Fitz and colleagues reported that myo-inositol likely causes fewer gastrointestinal side effects than metformin while achieving similar metabolic and hormonal improvements, which is one of the main reasons people gravitate toward it.
One caution worth noting: very high doses of D-chiro-inositol on its own have raised concerns in laboratory and animal studies, which is part of the rationale for using the physiological 40:1 myo-to-D-chiro ratio rather than large amounts of DCI alone. Even though inositol is a supplement, it is still worth discussing with your clinician, particularly if you are pregnant, trying to conceive, or taking other medications such as diabetes drugs that also lower blood sugar.
Can you combine metformin and inositol?
Yes, and some people do. Because the two work through different but complementary mechanisms, combining them is biologically reasonable, and a number of small trials have tested metformin plus inositol against metformin alone. Results are mixed but generally suggest the combination is at least as effective as metformin alone, sometimes with modest added benefit on ovulation or metabolic markers and potentially better tolerability if it allows a lower metformin dose.
The evidence is not strong enough to say combining is clearly superior for everyone, so this is a decision to make with a clinician rather than a default. The 2023 guideline treats inositol combined with other therapies as experimental for fertility outcomes. If cost, side effects, or fertility goals are in the mix, those factors often tip the balance.
How to choose
There is no single right answer, but a few practical considerations help:
- If metabolic features are prominent (insulin resistance, higher BMI, blood sugar concerns), metformin has the strongest evidence and is the typical first choice.
- If you want a gentler, lower-risk option and your symptoms are milder, inositol is a reasonable starting point; the 40:1 myo-to-D-chiro ratio is common, though the 2023 guideline does not endorse any specific form or dose.
- If you tried metformin and could not tolerate it, inositol is a common alternative worth discussing.
- If hirsutism or waist size is your main concern, the 2023 guideline favors metformin over inositol.
- If you are trying to conceive, both have been studied in this context, and the choice should be made with your fertility care team.
Whatever you choose, pair it with the foundations that help every PCOS plan: balanced nutrition, regular movement, sleep, and stress management. Our complete guide to PCOS walks through these in detail, and our deep dive on inositol for PCOS covers dosing forms and what to look for in a supplement. Metformin and inositol are not the only tools: combined oral contraceptives, spironolactone and letrozole are also used in PCOS, and our overview of PCOS treatment options looks at the wider menu.
Is metformin FDA approved for PCOS, and what about inositol?
Metformin is approved by the US Food and Drug Administration (FDA) for type 2 diabetes, not for PCOS. Doctors prescribe it for PCOS off label, which is legal and common, and the 2023 international guideline supports that use for metabolic features. Generic metformin is usually covered by insurance plans, although coverage for an off-label use varies by plan.
Inositol is regulated as a dietary supplement. The FDA does not review supplements for safety or effectiveness before they are sold, so the label dose and purity depend on the manufacturer. Inositol is usually paid for out of pocket. Look for products tested by an independent third party, and tell your prescriber which product and dose you take.
Who prescribes metformin or guides inositol use for PCOS?
PCOS care is usually led by an obstetrician-gynecologist (OB-GYN), a primary care physician, or an endocrinologist. A reproductive endocrinologist manages PCOS when fertility is the goal, and a dermatologist often sees the acne and hair symptoms. Registered dietitians help with the nutrition side, which the 2023 guideline treats as first-line care alongside any medication.
Some people also see integrative or functional medicine clinicians, who often recommend inositol and may prescribe metformin when they hold a medical license. Check that any clinician who manages PCOS can order labs such as fasting glucose, HbA1c, lipids and testosterone, and can coordinate with your gynecologist. If skin symptoms lead the picture, our guide to acne treatment options and the acne condition page cover androgen-driven breakouts.
Finding a clinician through the directory
Regenerated.com does not list PCOS as its own treatment hub yet. Many people start with hormone-focused practices, and the directory of hormone therapy clinics is one way to find them; check each profile for PCOS experience, because hormone replacement itself is not a PCOS treatment. Our hormone therapy treatment guide explains what those clinics typically offer.
Listing order on Regenerated.com is not paid ranking. Featured slots are labeled and capped, Verified means a clinic completed credential checks rather than paid for placement, and the directory is free for patients. Inclusion is not an endorsement, and our explainer on Featured, Verified and organic listings shows how to read each label.
Where do GLP-1 medications fit next to metformin and inositol?
GLP-1 receptor agonists such as semaglutide and tirzepatide are increasingly used when weight and insulin resistance are central to someone’s PCOS. The 2023 guideline says anti-obesity medications may be considered in adults with PCOS alongside lifestyle care, but they are not approved for PCOS itself and are not used during pregnancy or while trying to conceive.
They work differently from metformin and inositol, by slowing digestion and reducing appetite, and they carry their own digestive side effects and higher costs. Our post on GLP-1 medications for PCOS covers the evidence, and the compounded semaglutide guide explains how compounded versions differ from brand products. If you are unsure whether insulin resistance is part of your picture, our checklist of signs of insulin resistance is a useful starting point.
Frequently asked questions
Is inositol as effective as metformin for PCOS?
Inositol is about as effective as metformin for insulin sensitivity and testosterone levels, based on head-to-head trials pooled by Facchinetti and colleagues (2019). For clinical outcomes like hirsutism and waist-to-hip ratio, the 2023 International Evidence-based Guideline for PCOS leans toward metformin, though the data are not uniform. Effectiveness can also depend on the individual and on which symptoms matter most, such as cycles, skin, weight or fertility.
Which has fewer side effects?
Inositol has fewer side effects than metformin in most studies. Metformin commonly causes digestive upset such as nausea and diarrhea, especially in the first weeks, and can lower vitamin B12 over time with long-term use. Inositol’s side effects, when present, are usually mild bloating or nausea at higher doses. The review that informed the 2023 guideline found myo-inositol likely causes fewer gastrointestinal side effects than metformin.
Do I need a prescription for either one?
Metformin needs a prescription, and inositol does not. Metformin is a prescription medication, so a clinician has to prescribe it and monitor kidney function and B12. Inositol is sold over the counter as a dietary supplement. Even so, it is wise to involve a healthcare professional before starting either, especially if you are on other medications, have kidney problems, or are planning a pregnancy.
How long before I notice results?
Most people need three to six months to judge either metformin or inositol, because that is how long most PCOS trials run. Metabolic and hormonal changes often take weeks to months to show on lab work. Cycle regularity, in particular, can take several months to shift. Consistency matters more than speed, and your clinician can help track progress with labs and symptom review.
Can I take metformin and inositol together?
Yes, metformin and inositol can be taken together, and small trials suggest the combination is at least as effective as metformin alone. Some people combine them hoping to use a lower, better-tolerated metformin dose. The evidence is not strong enough to call the combination clearly superior, and the 2023 guideline treats inositol combinations as experimental for fertility, so agree on the plan and the doses with your prescriber.
Related reading
- The complete guide to PCOS
- Inositol for PCOS: forms, dosing, and what to look for
- PCOS and insulin resistance explained
- Hormonal acne: causes and treatment
This article is for education only and is not medical advice. Metformin is a prescription medication, and any treatment for PCOS should be started and monitored with a qualified healthcare professional who knows your history.
Frequently Asked Questions
Is metformin or inositol more effective for PCOS?
Metformin and inositol are similarly effective for insulin and testosterone, according to a meta-analysis of six trials and 355 women by Facchinetti and colleagues (2019). Metformin appears superior for outcomes such as waist-to-hip ratio and hirsutism score, according to the 2023 International Evidence-based Guideline for PCOS. A confident claim that one is clearly better across the board deserves caution, because the data do not support that level of certainty.
What does the evidence say about inositol for PCOS specifically?
The evidence for inositol in PCOS is promising for metabolic markers but limited for symptoms. Inositol acts as a second messenger inside cells, helping relay insulin’s signal, and is involved in the FSH signaling pathway in the ovaries. The 2023 guideline found the evidence for inositol on clinical outcomes was not strong enough for firm efficacy recommendations, and it could not recommend any specific form, dose or ratio. Effectiveness can also depend on the individual.
Do I need a prescription, or can I buy these over the counter?
Metformin requires a prescription, while inositol can be bought over the counter. Metformin is a prescription medication approved for type 2 diabetes and used off label in PCOS, with ongoing clinical oversight. Inositol is sold as a dietary supplement. Because inositol is not a regulated drug and the FDA does not approve supplements before sale, product quality and dosing can vary between brands, so third-party testing is worth looking for.
What are the side effects of metformin versus inositol?
Metformin causes more side effects than inositol, mainly nausea, diarrhea, gas and cramping that are worst at the start and often ease over time. Long-term metformin use can lower vitamin B12, and lactic acidosis is a rare but serious risk, so it is generally avoided when kidney function (eGFR) is below 30. Inositol is well tolerated for most people, with side effects usually mild and limited to nausea or bloating at higher doses.
How long does it take to see results?
Results from metformin or inositol usually take three to six months to judge, which matches the length of most PCOS trials. Metabolic and hormonal changes often take weeks to months to show on blood tests. Cycle regularity in particular can take several months to shift, so most clinicians recheck labs and symptoms after a few months of steady use rather than after a few weeks.
Who is each option best suited for?
Metformin tends to fit people with prominent metabolic features such as insulin resistance, higher BMI, or blood sugar concerns, and the 2023 guideline recommends it particularly in adults with a BMI of 25 or higher. Inositol suits people who want a gentler, lower-risk option for milder symptoms, or who could not tolerate metformin. The two are sometimes combined for fertility goals or better tolerability at lower metformin doses, though combining is not clearly superior.